Skip to main content

Booth Bruce's Form 4 filing

Kymera Therapeutics, Inc.KYMR · filed Jun 30, 2026

Accession no.
0001451612-26-000018
Filed
Jun 30, 2026
Trade date
Jun 26-29, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 30 non-derivative transactions. Open-market sales total $56.5M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Booth BruceCIK 0001451612Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 26, 2026Common StockSSaleDisposed−28,296$107.57F2−$3,043,800.722,834,055Indirect
Jun 26, 2026Common StockSSaleDisposed−231,007$108.14F4−$24,981,096.982,603,048Indirect
Jun 26, 2026Common StockSSaleDisposed−32,624$109.79F5−$3,581,788.962,570,424Indirect
Jun 26, 2026Common StockSSaleDisposed−11,277$110.49F6−$1,245,995.732,559,147Indirect
Jun 26, 2026Common StockSSaleDisposed−10,366$111.51F7−$1,155,912.662,548,781Indirect
Jun 26, 2026Common StockSSaleDisposed−555$112.49F8−$62,431.952,548,226Indirect
Jun 26, 2026Common StockSSaleDisposed−14,913$113.97F9−$1,699,634.612,533,313Indirect
Jun 26, 2026Common StockSSaleDisposed−27,951$114.94F10−$3,212,687.942,505,362Indirect
Jun 26, 2026Common StockSSaleDisposed−6,821$115.69F11−$789,121.492,498,541Indirect
Jun 26, 2026Common StockSSaleDisposed−12,181$117.09F12−$1,426,273.292,486,360Indirect
Jun 26, 2026Common StockSSaleDisposed−22,046$117.85F13−$2,598,121.12,464,314Indirect
Jun 26, 2026Common StockSSaleDisposed−12,390$118.66F14−$1,470,197.42,451,924Indirect
Jun 26, 2026Common StockSSaleDisposed−3,958$107.57F2−$425,762.06525,760Indirect
Jun 26, 2026Common StockSSaleDisposed−32,402$108.14F4−$3,503,952.28493,358Indirect
Jun 26, 2026Common StockSSaleDisposed−4,562$109.79F5−$500,861.98488,796Indirect
Jun 26, 2026Common StockSSaleDisposed−1,579$110.49F6−$174,463.71487,217Indirect
Jun 26, 2026Common StockSSaleDisposed−1,442$111.51F7−$160,797.42485,775Indirect
Jun 26, 2026Common StockSSaleDisposed−78$112.49F8−$8,774.22485,697Indirect
Jun 26, 2026Common StockSSaleDisposed−2,083$113.97F9−$237,399.51483,614Indirect
Jun 26, 2026Common StockSSaleDisposed−3,896$114.94F10−$447,806.24479,718Indirect
Jun 26, 2026Common StockSSaleDisposed−952$115.69F11−$110,136.88478,766Indirect
Jun 26, 2026Common StockSSaleDisposed−1,701$117.09F12−$199,170.09477,065Indirect
Jun 26, 2026Common StockSSaleDisposed−3,069$117.85F13−$361,681.65473,996Indirect
Jun 26, 2026Common StockSSaleDisposed−1,729$118.66F14−$205,163.14472,267Indirect
Jun 29, 2026Common StockSSaleDisposed−5,471$105.78F16−$578,722.382,446,453Indirect
Jun 29, 2026Common StockSSaleDisposed−14,613$106.63F17−$1,558,184.192,431,840Indirect
Jun 29, 2026Common StockSSaleDisposed−19,093$107.76F18−$2,057,461.682,412,747Indirect
Jun 29, 2026Common StockSSaleDisposed−848$105.78F16−$89,701.44471,419Indirect
Jun 29, 2026Common StockSSaleDisposed−2,318$106.63F17−$247,168.34469,101Indirect
Jun 29, 2026Common StockSSaleDisposed−3,024$107.76F18−$325,866.24466,077Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.995 to $107.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (2), (4) through (14), and (16) through (18).

Referenced by the price of 2 transactions in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to 108.9725 inclusive.

Referenced by the price of 2 transactions in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.02 to $110.0166 inclusive.

Referenced by the price of 2 transactions in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.02 to $111.0075 inclusive.

Referenced by the price of 2 transactions in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.1057 to $111.9188 inclusive.

Referenced by the price of 2 transactions in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.1843 to $113.0139 inclusive.

Referenced by the price of 2 transactions in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.2614 to $114.246 inclusive.

Referenced by the price of 2 transactions in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.2766 to $115.2672 inclusive.

Referenced by the price of 2 transactions in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.27 to $116.2626 inclusive.

Referenced by the price of 2 transactions in Table I.

F12

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.2731 to $117.2668 inclusive.

Referenced by the price of 2 transactions in Table I.

F13

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.2728 to $118.2599 inclusive.

Referenced by the price of 2 transactions in Table I.

F14

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.2717 to $119.035 inclusive.

Referenced by the price of 2 transactions in Table I.

F16

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.015 to $106.0145 inclusive.

Referenced by the price of 2 transactions in Table I.

F17

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.0271 to $106.96 inclusive.

Referenced by the price of 2 transactions in Table I.

F18

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.03 to $108.0293 inclusive.

Referenced by the price of 2 transactions in Table I.

Remarks

Due to the 30 line limitation in Table I, this report is being filed across two forms. This is the first of two filings.

Read the full filing on SEC EDGAR (opens in a new tab)